Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom; Children's Allergy Service, Evelina London, Guy's and St Thomas' Hospital, London, United Kingdom; Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
Pediatric Allergy Unit, Department of Pediatrics, University Hospitals of Geneva, Geneva, Switzerland.
J Allergy Clin Immunol Pract. 2021 May;9(5):2016-2027.e6. doi: 10.1016/j.jaip.2020.12.039. Epub 2020 Dec 29.
Nut allergic patients are often IgE sensitized to other nuts/seeds and need multiple oral food challenges (OFCs) before the safe nuts can be introduced in the diet. However, OFCs are time-consuming and risky procedures.
To assess the utility of the basophil activation test (BAT) to predict the allergic status and reduce the need for an OFC in children with 1 or more nut or seed allergies.
Participants in the Pronuts study recruited at the Geneva and the London centers were tested on the BAT to hazelnut, cashew nut, sesame, almond, and peanut, Ara h 1, Ara h 2, Ara h 6, using FlowCAST, a commercially available BAT kit, and flow cytometry.
The BAT to hazelnut, cashew nut, sesame, almond, and peanut discriminated between allergic and nonallergic children, to the respective nut or seed. The optimal allergen concentration and their optimal, positive, and negative cutoffs were identified for the BAT and the other tests, for each nut and seed. Using the BAT as a second step in the diagnostic process, after equivocal skin prick test and IgE to extracts and components, reduced the number of total OFCs by 5% to 15% and positive OFCs by 33% to 75% (except for hazelnut) with 0% false-negatives and a diagnostic accuracy of 96% to 100%.
The BAT proved to be a useful diagnostic tool, used in a stepwise approach, to predict the allergic status and reduce the number of OFCs in the Pronuts study participants with at least 1 nut allergy willing to consume selected nuts.
坚果过敏患者通常对其他坚果/种子过敏,需要进行多次口服食物挑战(OFC),才能将安全的坚果引入饮食。然而,OFC 是耗时且有风险的程序。
评估嗜碱性粒细胞激活试验(BAT)在预测过敏状态和减少对至少有 1 种坚果过敏并愿意食用特定坚果的儿童进行 OFC 需求方面的效用。
在日内瓦和伦敦中心招募的 Pronuts 研究参与者接受了针对榛子、腰果、芝麻、杏仁和花生、Ara h 1、Ara h 2、Ara h 6 的 BAT 测试,使用 FlowCAST(一种商业上可用的 BAT 试剂盒)和流式细胞术。
榛子、腰果、芝麻、杏仁和花生的 BAT 能够区分过敏和非过敏儿童,与相应的坚果或种子有关。为每种坚果和种子确定了 BAT 及其它测试的最佳过敏原浓度及其最佳、阳性和阴性截止值。在皮肤点刺试验和提取物及成分 IgE 结果不确定的情况下,将 BAT 作为诊断过程中的第二步,将总 OFC 的数量减少了 5%至 15%,阳性 OFC 的数量减少了 33%至 75%(除了榛子),假阴性率为 0%,诊断准确性为 96%至 100%。
在 Pronuts 研究参与者中,BAT 证明是一种有用的诊断工具,用于逐步预测过敏状态并减少至少有 1 种坚果过敏并愿意食用特定坚果的儿童的 OFC 数量。